BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 19
• 20
• 21
• 22
• 23
• 24
• 26
• 27
• 28
• 29
• 30

• FDA

  Abbott’s MitraClip Approved as First Transcatheter Mitral Valve Repair Device in Japan

  The MitraClip system is a catheter-based, minimally-invasive therapy that is delivered to the heart through a blood vessel in the leg.

  November 6, 2017

   · 

  4 min read
• Business

  Strongbridge Biopharma plc to Host Third Quarter 2017 Financial Results Conference Call on November 14, 2017

  The conference call will follow the anticipated release of the Company’s financial results earlier that day.

  November 6, 2017

   · 

  2 min read
• Business

  Henry Schein Reports Record 3rd Quarter Financial Results

  All per share figures in this news release reflect the 2-for-1 common stock split that Henry Schein completed during the third quarter of 2017.

  November 6, 2017

   · 

  24 min read
• Business

  Thermo Fisher Scientific and Cellular Biomedicine Group Announce Strategic Partnership to Develop Manufacturing Processes

  The partnership focuses on the research and development of an automated cell therapy manufacturing system.

  November 6, 2017

   · 

  6 min read
• Business

  Myriad Genetics Collaborates With CareFirst BlueCross BlueShield on Coverage with Evidence Development (CED) Study for the Vectra DA Test

  Vectra DA is a pioneering test designed to predict whether patients with RA are at risk for radiographic progression (RP) so that rheumatologists can optimize treatment decisions.

  November 6, 2017

   · 

  8 min read
• Business

  Heron Therapeutics Reports Financial Results for the Three and Nine Months Ended September 30, 2017 and Recent Corporate Progress

  Net product sales of SUSTOL for the three months ended September 30, 2017 were $8.6 million and totaled $20.7 million for the nine months ended September 30, 2017.

  November 6, 2017

   · 

  6 min read
• Business

  Peterson’s Lab Entered Strategic Cooperation With Shanghai Corday Biotech Ltd.

  The five-year agreement includes certain minimum purchases and may be extended through mutual agreement.

  November 6, 2017

   · 

  1 min read
• Drug Development

  G1 Therapeutics Announces Publication in Cancer Discovery Demonstrating That CDK4/6 Inhibition Enhances the Anti-Tumor T Cell Response

  Intermittent dosing of G1’s CDK4/6 inhibitor trilaciclib enhances anti-tumor efficacy of checkpoint inhibitors in preclinical models.

  November 6, 2017

   · 

  3 min read
• Drug Development

  Omeros’ Extended Improvement in OMS721-Treated Patients With IgA Nephropathy Presented at American Society of Nephrology Annual Meeting

  During the Phase 2 clinical trial, which consisted of 12 weeks of treatment and 6 weeks of follow-up, all patients with IgA nephropathy demonstrated clinically meaningful improvement in proteinuria.

  November 6, 2017

   · 

  8 min read
• Pharm Country

  Alcresta Therapeutics Presented Results at the North American Cystic Fibrosis Conference from the ASSURE Study: An Evaluation of the Long-Term Use of RELiZORB

  Data from the ASSURE study was shared at the North American Cystic Fibrosis Conference that took place November 2-4, 2017 in Indianapolis.

  November 6, 2017

   · 

  4 min read